WJA
PAHC icon

Williams Jones & Associates’s Phibro Animal Health PAHC Stock Holding History

Williams Jones & Associates’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,775
Closed -$205K – 421
2018
Q3 		$205K Buy
+4,775
New +$226K ﹤0.01% 407

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Williams Jones & Associates's PAHC Position: Q4 2018 in Review

Williams Jones & Associates sold out of Phibro Animal Health (PAHC) in Q4 2018, closing a stake of 4,775 shares — an estimated $205K sold.

Williams Jones & Associates first reported a position in PAHC in Q3 2018 and held it in 1 quarter. The position peaked at $205K in Q3 2018. 191 funds tracked by Wall St. Rank hold PAHC as of Q4 2018.

  • Williams Jones & Associates reported no remaining Phibro Animal Health position as of Q4 2018 after selling out during the quarter.
  • Williams Jones & Associates sold 4,775 Phibro Animal Health shares in Q4 2018, an estimated $205K.
  • Williams Jones & Associates first reported a position in Phibro Animal Health in Q3 2018 and held it in 1 quarter.
  • Williams Jones & Associates's Phibro Animal Health position peaked at $205K in Q3 2018.
  • 191 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2018.

Based on Williams Jones & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.